These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33748035)

  • 1. Fecal Calprotectin in Combination With Standard Blood Tests in the Diagnosis of Inflammatory Bowel Disease in Children.
    Ho SSC; Ross M; Keenan JI; Day AS
    Front Pediatr; 2020; 8():609279. PubMed ID: 33748035
    [No Abstract]   [Full Text] [Related]  

  • 2. Fecal calprotectin: a selection tool for small bowel capsule endoscopy in suspected IBD with prior negative bi-directional endoscopy.
    Koulaouzidis A; Douglas S; Rogers MA; Arnott ID; Plevris JN
    Scand J Gastroenterol; 2011 May; 46(5):561-6. PubMed ID: 21269246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unrestricted faecal calprotectin testing performs poorly in the diagnosis of inflammatory bowel disease in patients in primary care.
    Conroy S; Hale MF; Cross SS; Swallow K; Sidhu RH; Sargur R; Lobo AJ
    J Clin Pathol; 2018 Apr; 71(4):316-322. PubMed ID: 28844038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid fecal calprotectin testing to assess for endoscopic disease activity in inflammatory bowel disease: A diagnostic cohort study.
    Kwapisz L; Mosli M; Chande N; Yan B; Beaton M; Micsko J; Mennill PW; Barnett W; Bax K; Ponich T; Howard J; Tirolese A; Lannigan R; Gregor J
    Saudi J Gastroenterol; 2015; 21(6):360-6. PubMed ID: 26655130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive testing in the management of children with suspected inflammatory bowel disease.
    Dilillo D; Zuccotti GV; Galli E; Meneghin F; Dell'Era A; Penagini F; Colella G; Lewindon P; Carmagnola S; Farina E; Ardizzone S; Maconi G
    Scand J Gastroenterol; 2019 May; 54(5):586-591. PubMed ID: 31032665
    [No Abstract]   [Full Text] [Related]  

  • 7. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
    Kostas A; Siakavellas SI; Kosmidis C; Takou A; Nikou J; Maropoulos G; Vlachogiannakos J; Papatheodoridis GV; Papaconstantinou I; Bamias G
    World J Gastroenterol; 2017 Nov; 23(41):7387-7396. PubMed ID: 29151692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity.
    Lee YW; Lee KM; Lee JM; Chung YY; Kim DB; Kim YJ; Chung WC; Paik CN
    Korean J Intern Med; 2019 Jan; 34(1):72-80. PubMed ID: 29347813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of Rapid Fecal Calprotectin Test in Monitoring Inflammatory Bowel Diseases Under Treatment with TNFα Antagonists.
    Tursi A; Elisei W; Picchio M; Giorgetti G; Brandimarte G
    Dig Dis Sci; 2015 May; 60(5):1406-13. PubMed ID: 25445163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Fecal Calprotectin With Endoscopic and Histologic Activity in Pediatric Inflammatory Bowel Disease.
    Crawford E; Gestrich C; Malay S; Young D; Perry S; Splawski J; Sferra TJ; Saab S; Moses J
    JPGN Rep; 2021 Nov; 2(4):e129. PubMed ID: 37206450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal Calprotectin for Small Bowel Crohn's Disease: Is It a Cutoff Issue?
    Romero-Mascarell C; Fernández-Esparrach G; Rodríguez-De Miguel C; Masamunt MC; Rodríguez S; Rimola J; Urpí M; Casanova GS; Ordás I; Ricart E; Caballol B; Fernández-Clotet A; Panés J; Llach J; González-Suárez B
    Diagnostics (Basel); 2022 Sep; 12(9):. PubMed ID: 36140627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children.
    Sidler MA; Leach ST; Day AS
    Inflamm Bowel Dis; 2008 Mar; 14(3):359-66. PubMed ID: 18050298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Percentage of IBD Patients with Indefinite Fecal Calprotectin Levels: Additional Value of a Combination Score.
    Bodelier AG; Jonkers D; van den Heuvel T; de Boer E; Hameeteman W; Masclee AA; Pierik MJ
    Dig Dis Sci; 2017 Feb; 62(2):465-472. PubMed ID: 27933473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes at 12 months and risk of inflammatory bowel disease in patients with an intermediate raised fecal calprotectin: a 'real-world' view.
    McFarlane M; Chambers S; Malik A; Lee B; Sung E; Nwokolo C; Waugh N; Arasaradnam R
    BMJ Open; 2016 Jun; 6(6):e011041. PubMed ID: 27266773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal calprotectin in assessing inflammatory bowel disease endoscopic activity: a diagnostic accuracy meta-analysis.
    Rokkas T; Portincasa P; Koutroubakis IE
    J Gastrointestin Liver Dis; 2018 Sep; 27(3):299-306. PubMed ID: 30240474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P019 Not All Fecal Calprotectin is Specific for Inflammatory Bowel Disease.
    Gueorguieva I; Jacobs R; Piper M
    Am J Gastroenterol; 2021 Dec; 116(Suppl 1):S5. PubMed ID: 37461939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin.
    Cao Y; Dai Y; Zhang L; Wang D; Hu W; Yu Q; Wang X; Yu P; Liu W; Ping Y; Sun T; Sang Y; Liu Z; Chen Y; Tao Z
    J Inflamm Res; 2021; 14():6409-6419. PubMed ID: 34880643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative Effects on Psychological Health and Quality of Life of Genuine Irritable Bowel Syndrome-type Symptoms in Patients With Inflammatory Bowel Disease.
    Gracie DJ; Williams CJ; Sood R; Mumtaz S; Bholah MH; Hamlin PJ; Ford AC
    Clin Gastroenterol Hepatol; 2017 Mar; 15(3):376-384.e5. PubMed ID: 27189912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease.
    Rosenfeld G; Greenup AJ; Round A; Takach O; Halparin L; Saadeddin A; Ho JK; Lee T; Enns R; Bressler B
    World J Gastroenterol; 2016 Sep; 22(36):8211-8. PubMed ID: 27688663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders.
    Caviglia GP; Pantaleoni S; Touscoz GA; Adriani A; Rosso C; Smedile A; Pellicano R; Astegiano M; Bresso F
    Scand J Gastroenterol; 2014 Dec; 49(12):1419-24. PubMed ID: 25369978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.